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Abstract
In medium spiny neurons (MSNs) of the striatum, dopamine D2 receptors (D2Rs) specifically
inhibit the Cav1.3 subtype of L-type Ca
2+ channels (LTCs). MSNs are heterogeneous in
their expression of dopamine receptors making the study of D2R pathways difficult in pri-
mary neurons. Here, we employed the ST14A cell line, derived from embryonic striatum
and characterized to have properties of MSNs, to study Cav1.3 current and its modulation
by neurotransmitters. Round, undifferentiated ST14A cells exhibited little to no endogenous
Ca2+ current while differentiated ST14A cells expressed endogenous Ca2+ current. Trans-
fection with LTC subunits produced functional Cav1.3 current from round cells, providing a
homogeneous model system compared to native MSNs for studying D2R pathways. How-
ever, neither endogenous nor recombinant Cav1.3 current was modulated by the D2R ago-
nist quinpirole. We confirmed D2R expression in ST14A cells and also detected D1Rs,
D4Rs, D5Rs, Gq, calcineurin and phospholipase A2 using RT-PCR and/or Western blot anal-
ysis. Phospholipase C β-1 (PLCβ-1) expression was not detected by Western blot analysis
which may account for the lack of LTC modulation by D2Rs. These findings raise caution
about the assumption that the presence of G-protein coupled receptors in cell lines indicates
the presence of complete signaling cascades. However, exogenous arachidonic acid inhib-
ited recombinant Cav1.3 current indicating that channels expressed in ST14A cells are
capable of modulation since they respond to a known signaling molecule downstream of
D2Rs. Thus, ST14A cells provide a MSN-like cell line for studying channel modulation and
signaling pathways that do not involve activation of PLCβ-1.
Introduction
Two classes of L-type Ca2+ channel (LTC) α1 subunits are expressed in the brain: α1C (CaV1.2)
and α1D (CaV1.3) [1] with highest expression in cerebral cortex and striatum [2]. While differ-
ing in biophysical properties and pharmacological sensitivities, both LTCs contribute to
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membrane excitability, synaptic regulation and gene transcription [3]. In turn, neurotransmit-
ters act via G-protein coupled receptors (GPCRs) to modulate membrane excitability and alter
transfer of information within neural circuits. Modulation of LTCs by dopamine GPCR signal-
ing pathways is important in medium spiny neurons (MSN) of the striatum since these neu-
rons are the only source of output from the striatum [4] and are adversely affected in both
Parkinson’s and Huntington’s Diseases [5, 6].
Two families of dopamine receptors exist. The D1-like receptor family (D1R, D5R), couples
to the G protein Gs, enhancing L-current [7, 8] and the firing rate of MSNs [7]. Conversely, the
D2-like receptor family (D2R, D3R, D4R) couples to Gi/o [9], inhibiting L-current [10] and the
firing rate of MSNs [11]. Two heterogeneous groups of MSNs respond to dopaminergic input:
D1R-expressing MSNs and D2R-expressing MSNs, which are associated with the direct and
indirect output, respectively [6]. The balance of output pathways between the opposing D1R-
and D2R-expressing MSNs coordinates motor control [12]. Consequently drugs developed to
treat Parkinson’s disease target dopamine receptors, particularly D2Rs [13] and more recently
LTCs [14, 15]. MSNs express both CaV1.2 and CaV1.3, but D2R activation inhibits only CaV1.3
[11]. In Parkinson’s disease models, loss of D2R modulation of CaV1.3 leads to loss of dendritic
spines [16]. Therefore, the pathway underlying D2R modulation of LTC current appears criti-
cal for normal function; however due to dopamine receptor heterogeneity in MSNs, the molec-
ular relationship between D2Rs and LTCs has been difficult to elucidate.
Moreover, two different mechanisms may mediate D2R inhibition of LTC current. One
characterized pathway involves Gq, phospholipase C (PLC), inositol triphosphate (IP3)-
induced Ca2+ release, and protein phosphatase 2B (PP2B) also known as calcineurin [10].
Additionally, D2R activation releases arachidonic acid (AA) in vivo [17–20], in primary neu-
rons [21] and in transfected cell lines [22]. Our laboratory has demonstrated that exogenously
applied AA inhibits LTC currents in superior cervical ganglion neurons (SCG) [23–25]. These
currents are most likely exclusively due to CaV1.3 current [26]. Additionally, we have shown
that AA inhibits recombinant CaV1.3 currents when expressed in HEK293 cells [27]. There-
fore, a second D2R signaling pathway inhibiting CaV1.3 may involve activation of Ca
2+-
-dependent cytosolic phospholipase A2 (cPLA2), which cleaves AA from phospholipids,
similar to M1 muscarinic receptor (M1R) modulation of LTC current in SCG [25].
In the present study, we developed a model system to probe the D2R signaling pathway
inhibiting CaV1.3 using the ST14A cell line, created from embryonic rat striatum [28]. Retrovi-
ral transduction of the temperature-sensitive SV40 large T antigen enables ST14A cells to grow
and divide at the permissive temperature of 33°C. At higher temperatures the cells differentiate
to exhibit general neuronal, as well as specific MSN-like, properties including functional D2-
like receptors [28, 29]. We examined whether ST14A cells express identified signaling mole-
cules downstream of D2Rs in an effort to develop a model cell line with MSN properties to
study the functional effects of D2R signaling on CaV1.3. We found that round ST14A cells
lacked endogenous Ca2+ current and exploited this deficiency by transfecting cells with CaV1.3
and accessory subunits, thus eliminating the need for pharmacological blockers. Recombinant
CaV1.3 currents were characterized and tested for current modulation by the D2 dopamine
agonist quinpirole and by exogenous AA.
Materials and Methods
Preparation of Cells
The ST14A cell line, created by Elena Cattaneo and described in Cattaneo and Conti, 1998
[28], was given to us as a gift from Dr. Michelle E. Ehrlich (Jefferson Medical School) with per-
mission from Dr. Elena Cattaneo (University of Milano). ST14A cells were propagated at the
L-Type Ca2+ Channel Modulation in ST14A Cells
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permissive temperature of 33°C in Dulbecco’s modified Eagle’s medium (DMEM; Gibco) sup-
plemented with 0.11 g/L sodium bicarbonate (Sigma, St. Louis, MO), 0.29 g/L L-glutamine, 3.9
g/liter HEPES, 100 units/ml penicillin-streptomycin, and 10% fetal bovine serum (FBS; Invitro-
gen, Carlsbac, CA). Cells were transferred to 37°C to promote differentiation and used 1–2
days later. The A9L cell line, derived from A9 L cells co-transfected with the human D2R and
obtained from the American Type Culture Collection (ATCC, Manassas, VA), were propa-
gated at 37°C in DMEM with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbon-
ate and 4.5 g/L glucose containing 10% FBS. HEK 293 cells were propagated at 37°C in
DMEM/F12 containing 10% FBS. All cells were maintained in a temperature-controlled
humidified incubator at 5% CO2 and passaged once flasks became 80–90% confluent. SCG,
striatum and cortex of 1 to 4-day old or adult Sprague-Dawley rats (Charles River Laboratories,
Wilmington, MA) were isolated following CO2 exposure and decapitation using a protocol
(protocol # 822) approved by the Institutional Animal Care and Use Committee (IACUC) of
University of Massachusetts Medical School. This study was carried out in strict accordance
with the recommendations in the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health. All efforts were made to minimize animal suffering. The Institu-
tional Animal Care and Use Committee (IACUC) of University of Massachusetts Medical
School specifically approved animal use for this study.
Electrophysiology
Whole-cell currents were recorded at room temperature (RT, 20–24°C) with an Axon 200B
patch clamp amplifier (Molecular Devices, Sunnyvale, CA). Currents were filtered at 1–5 kHz
and digitized at 5 times the filter cut-off frequency of the 4-pole Bessel filter of the amplifier.
Electrodes were pulled from borosilicate glass capillary tubes and each electrode was fire-pol-
ished to ~1 m to give the pipette a resistance of 2–3 M. The pipette solution consisted of (in
mM): 125 Cs-Aspartate, 10 HEPES, 0.1 BAPTA, 5 MgCl2, 4 ATP and 0.4 GTP brought to pH
7.50 with CsOH. High resistance seals were established in Ca2+ Tyrode’s consisting of (in mM):
5 CaCl2, 145 NaCl, 5.4 KCl, and 10 HEPES brought to pH 7.50 with NaOH. Once a seal was
established and the membrane ruptured, the Tyrode’s solution was exchanged for an external
bath solution consisting of (in mM): 125 NMG-Aspartate, 20 Ba2+, 10 HEPES brought to pH
7.50 with CsOH.
FPL 64176 and nimodipine were prepared as stock solutions in 100% ethanol and stored at
-20°C. AA (5,8,11,14-eicosatetraenoic acid; NuCheck Prep, Elysian, MN) and oleic acid
(NuCheck Prep) were dissolved in 100% ethanol and stored under nitrogen as stock solutions
at -70°C. ω-conotoxin GVIA (Bachem, Torrence, CA) and quinpirole were prepared as stock
solutions in double distilled water and stored at -70°C. Oxotremorine-M (Tocris, Ellisville,
MO) was prepared fresh daily by making a 10 mM stock in double distilled water. Working
dilutions were made fresh daily by diluting stock solutions at least 1:1,000 with external bath
solution. For ethanol prepared stocks, the final ethanol concentration was less than 0.1%.
Bovine serum albumin (BSA; fraction V, heat shock, fatty acid ultra-free; Roche Applied Sci-
ence, Indianapolis, IN) was added directly to the bath solution for a final concentration of 1
mg/ml. All chemicals were purchased from Sigma unless otherwise noted.
Data were acquired using Signal 2.14 software (Cambridge Electronic Design, Cambridge,
England) and stored for later analysis on a personal computer. Linear leak and capacitive cur-
rents were subtracted from all traces. Data are presented as the mean ± s.e.m. Significance was
determined statistically using a two-tailed paired or unpaired t-test, or a one-way ANOVA.
Analysis programs include Signal (Cambridge Electronic Design), Excel (Microsoft, Redmond,
WA) and Origin (OriginLab, Northampton, MA).
L-Type Ca2+ Channel Modulation in ST14A Cells
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Transfection
ST14A cells were transfected by lipofectamine (Invitrogen, Carlsbad, CA) with a 1:1:1 molar
ratio of CaV1.3, β2a, and α2δ subunits [30]. Constructs for CaV1.3b (+exon11, Δexon32, +-
exon42a; GenBank accession #AF370009), and α2δ-1 (GenBank accession #AF286488) were a
gift from Dr. Diane Lipscombe (Brown University) and the construct for CaVβ2a (GenBank
accession #M80545) was a gift from Dr. Edward Perez-Reyes (University of Virginia). For all
transfections, 0.4 μg of DNA was used per well of a 12-well plate. Prior to transfection, cells
were washed with DMEM. The DNA mixture was then added dropwise to each well, gently
swirled then incubated for 1–3 h at 37°C in a 5% CO2 incubator. Supplemented media, without
antibiotics, was returned to the wells to bring the volume up to 1 ml (normal growth medium
volume). Cells were washed with full media 2 and 4 h later and assayed for transient gene
expression after 24–72 h.
Reverse Transcriptase-Polymerase Chain Reaction
Homogenized tissue samples (50–100 mg) or confluent cells in a 100 mm dish were lysed in 1
ml TRIzol Reagent (Invitrogen). RNA was separated from DNA by phenol-chloroform phase
separation. RNA was precipitated with isopropyl alcohol and washed with 75% ethanol. The
RNA pellet was dried and resuspended in RNase-free water. RNA samples had an A260/A280
ratio between 1.6 and 1.8 and were treated with DNase to eliminate contamination with geno-
mic DNA. For reverse transcription, cDNA was synthesized from the mRNA by adding 1 μl
10X buffer RT, 1 μl dNTP Mix (5 mM each dNTP), 1 μl Oligo-dT primer (0.5 mg/ml, Promega,
Madison, WI), 0.125 μl RNase Inhibitor (40 U/μl, Promega), 0.5 μl Omniscript Reverse Tran-
scriptase (4 U/μl) and RNase-free water for a total volume of 10 μl (all reagents from QIAGEN,
Valencia, CA, unless otherwise noted). The mixture was incubated at 37°C for 1 h. The mixture
was then heated at 93°C for 5 min and then placed on ice to inactivate the transcriptase. PCR
amplification was then performed with a Techgene thermal cycler (Techne Inc, Burlington,
NJ) with thin walled PCR tubes.
PCR primers for dopamine receptors D1-D5 (D5 formerly referred to as D1b) were sequences
previously published [31]. D1: 5’-GAC AAC TGT GAC ACA AGG TTG AGC-3’ and 5’-ATT
ACA GTC CTT GGA GAT GGA GAT GGA GCC-3’ yields a 609 base pair (bp) product. D2: 5’-
GCA GTC GAG CTT TCA GAG CC-3’ and 5’-TCT GCG GCT CAT CGT CTT AAG-3’ yields
404 and 317 bp products recognizing the long and short forms of the D2R, respectively. D3:
5’-AGC ATC TGC TCC ATC TCC AAC CC-3’ and 5’-A GGA GTT CCG AGT CCT TTC CAC
G-3’ yields a 461 bp product. D4: 5’-TC ATG CTA CTG CTT TAC TGG GCC A-3’ and 5’-
T CTG AGA GAG GTC TGA CTC TGG TC-3’ yields a 223 bp product. D5: 5’-AGT CGT GGA
GCC TAT GAA CCT GAC-3’ and 5’-GCG TCG TTG GAG AGA TTT GAG ACA-3’ yields a
517 bp product. GAD65 and GAD67 primers were from sequences previously published [32].
GAD65: 5’-CGC CCC TGT ATT TGT ACT AC-3’ and 5’-GCC AAG AGA GGA TCA AAA
GC-3’ yields a 400 bp product. GAD67: 5’CAC ACC AGT TGC TGG AAG-3’ and 5’- ACA
AAC ACG GGT GCA ATT-3’ yields 318 and 238 bp products. GAPDH primers were from
sequences previously published [33]. GAPDH: 5’-TGC CAA GGC TGT GGG CAA GG-3’ and
5’-GCT TCA CCA CCT TCT TGA TG-3’ yields a 199 bp product and confirmed equal
loading.
Reaction mixtures for PCR contained 200 ng of cDNA, 5 μl of 2.5 X Eppendorf MasterMix
[Taq DNA Polymerase (62.5 U/ml), 125 mM KCl, 75 mM Tris-HCl, 3.75 mMMg(OAc)2,
0.25% Igepal-CA630, 500 μM of each dNTP and stabilizers, Brinkmann, Westbury, NY], 1 μl
each of forward and reverse primer (5 pmol/ μl, Invitrogen for dopamine receptors and GAD;
Qiagen for GAPDH), 2 to 4 mMMg2+ (Brinkmann) and distilled water to a final volume of
L-Type Ca2+ Channel Modulation in ST14A Cells
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12.5 μl. High (4 mM) Mg2+ concentrations were necessary to amplify dopamine receptor
mRNAs. The protocol for dopamine receptor amplification was 94°C for 1 min, 58°C for 1
min, and 72°C for 3 min for 20 cycles [31]. For the D3R, an annealing temperature of 62°C was
also tried. For GAD amplification, the protocol was 94°C for 3 min, 53°C for 1 min, 52°C for 1
min, 51°C for 1 min, and 70°C for 2 min for 30 cycles [32]. A 2 μl aliquot was used as a tem-
plate for a second round of amplification for thirty cycles. PCR products and a 100 bp DNA
ladder (Invitrogen; bright band 600 bp or Promega, Madison, WI; bright band 500 bp) were
separated by electrophoresis in 2% agarose gels stained with ethidium bromide. Bands excised
from gels were sequenced by the UMASS Medical School Nucleic Acid Facility and compared
to published sequences (GenBank accession number): D1 (M35077), D2 (M36831), D4
(M84009), D5 (M69118), GAD65 (M74826), and GAD67 (M81883).
Western Blot Analysis
The immunoblot protocol has been previously described [34]. All extracts and buffers con-
tained protease inhibitors (Santa Cruz Biotechnology, Santa Cruz, CA): pepstatin A (1μg/ml),
leupeptin (10 μg/ml), aprotinin (20 μg/ml), phenylmethanesulfonyl fluoride (200 nM), and cal-
pain inhibitor I and II (8 μg/ml each). Day 4 rat brain or cells grown in uncoated 60-mm dishes
were solubilized in lysis buffer (0.15 M NaCl, 5 mM EDTA, 1% Triton-X 100, 10 mM Tris-Cl
pH 7.4), sonicated, and centrifuged to remove insoluble material. Protein concentration was
determined by the RC/DC assay (Bio-Rad, Hercules, CA). 20–30 μg of protein was loaded per
lane and separated on 8% SDS-polyacrylamide gels. Equal protein loading was confirmed by
staining with β-actin antibodies.
Antibodies used include:monoclonal- D2R (1:400; Santa Cruz Biotechnology), PP2B and β-
actin (1:500 and 1:10,000; Sigma); polyclonal- M1R and Gqα (1:1,000; Santa Cruz Biotechnol-
ogy), cPLA2 (1:200; Cell Signaling Technology, Danvers, MA), PLCβ-1 (1:200; Millipore, Biller-
ica, MA); secondary- HRP-conjugated goat anti-mouse or bovine anti-rabbit (1:15,000 or
1:10,000; Santa Cruz Biotechnology). Primary and secondary antibodies were diluted with PBS.
Results
To determine if ST14A cells express endogenous Ca2+ current, we measured whole-cell cur-
rents from cells grown at 33 or 37°C. Two populations of cells were distinguished based on
morphology: round or differentiated, with the definition of having neuron-like projections.
From a holding potential of -90 mV, round cells exhibited zero to little endogenous peak or tail
current measured at +10 mV or -40 mV respectively, regardless of the temperature at which
the cells were grown (Fig 1A). Differentiated cells had significantly more endogenous current
than round cells at both potentials (Fig 1B). Application of the LTC agonist, FPL 64176 (FPL;
1 μM) enhanced endogenous currents at both potentials (Fig 1A and 1B), indicating that at
least a component of the endogenous current was LTC. Since round cells showed little to no
LTC current, we transfected the ST14A cells with LTC channel subunits, CaV1.3, β2a, and α2δ-
1, along with green fluorescent protein (GFP) and recorded whole-cell currents from green
fluorescing round cells (Fig 1C). Peak and tail currents from round transfected cells were sig-
nificantly larger than those recorded from round untransfected cells (Fig 1A and 1B). FPL sig-
nificantly enhanced recombinant current at -40 mV. Fig 1D shows representative individual
traces of round endogenous or round recombinant current before and after application of FPL.
The recombinant current shows little to no inactivation with 20 mM Ba2+ as the charge carrier
[35], typical of LTC current coexpressed with the accessory subunit, β2a [36].
Since CaV1.3 activates at more negative voltages compared to CaV1.2 [30], we measured
peak current at -10 mV. Recombinant current recorded at -10 mV was larger than at +10 mV
L-Type Ca2+ Channel Modulation in ST14A Cells
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Fig 1. ST14A cells have endogenous Ca2+ currents but are capable of expressing recombinant
current. (A-B) Currents were recorded from round (undifferentiated, no processes) or differentiated (having
processes) endogenous ST14A cells. Note: round cells from ST14A cells grown at either 33°C or 37°C
exhibited little to no current and were pooled. Currents were recorded from round ST14A cells grown at 33°C,
transfected and grown at 37°C for at least 24 hours before recording. Each set of cells were recorded in the
absence (white bars) and presence of 1 μMFPL (black bars). Summary of peak Ca2+ currents measured
from a holding potential of -90 mV to a test potential of +10 mV (A) and then to a tail potential of -40 mV (B).
L-Type Ca2+ Channel Modulation in ST14A Cells
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(Fig 1A) and this increase was also reflected in the tail current amplitude at -40 mV (Fig 1B).
The summary of these results shows that round ST14A cells have little endogenous LTC cur-
rent but are capable of being transfected with LTCs and expressing functional LTC currents.
Therefore, the round cells represent a population of ST14A cells that we used to study recombi-
nant LTC function in isolation from other types of native Ca2+ channels.
We characterized recombinant CaV1.3 current further to determine whether transfected
channel activity in ST14A cells exhibits biophysical and pharmacological properties of CaV1.3
observed in oocytes and HEK 293 cells [30]. First, we measured peak current across a range of
voltages to show that channels open at relatively negative voltages compared to CaV1.2 [30].
Indeed, in 20 mM Ba2+, CaV1.3 currents activated at a test potential of -60 mV and peaked at
-10 mV to 0 mV (Fig 2A). Recombinant current in ST14A cells exhibited a CaV1.3 LTC phar-
macological profile. Fig 2B shows a time course of the effects of Ca2+ channel ligands on
CaV1.3 current. The current was insensitive to the N-type Ca
2+ channel antagonist, ω-
-conotoxin GVIA (1 μM; CTX) but was inhibited in a concentration-dependent manner by the
LTC antagonist, nimodipine (0.1–3.0 μM; NIM). The inhibition produced by 1.0 μMNIM
(51.8 ± 4%) is characteristic of the low-voltage sensitivity of CaV1.3 compared to CaV1.2,
which would be fully blocked by 1.0 μMNIM [30]. Inhibition fully reversed by washing with
bath solution. After wash out, channels remained sensitive to FPL. The antagonist data are
summarized in the bar graph in Fig 2C. These findings show that recombinant current in
ST14A cells displayed both current-voltage and pharmacological profiles specific to CaV1.3
channels.
To determine whether D2R activation by the agonist quinpirole (Quin) inhibits CaV1.3 cur-
rents in ST14A cells, we recorded recombinant currents in the presence of FPL to enhance cur-
rent amplitude. At a concentration of 10 μM, Quin had no significant effect on peak or tail
current amplitude over time, (Fig 3A left) or in individual traces (Fig 3A right). To determine if
only recombinant CaV1.3 current was insensitive to D2R activation, we tested whether endoge-
nous ST14A current from differentiated cells could undergo modulation. Again 10 μMQuin
had no significant effect on endogenous peak or long-lasting tail current amplitude. Fig 3B
shows representative current traces in the presence of 1 μM FPL from a range of voltages before
and after Quin. Since a majority of MSNs express muscarinic M1 receptors (M1Rs) as well as
dopamine receptors [37], we tested whether activation of this receptor would inhibit endoge-
nous current. The muscarinic agonist oxotremorine-M (Oxo-M; 10 μM) had no effect on
endogenous peak or long-lasting tail current amplitude. Fig 3C shows representative current
traces in the presence of FPL from a range of voltages (-60 mV to -10 mV) tested before and
after Oxo-M. Fig 3D summarizes the effect of Quin and Oxo-M on peak (left) and long-lasting
tail current (right) from recombinant CaV1.3 versus endogenous ST14A current. These results
suggest that the D2R and M1R signaling pathways, which inhibit LTC current in MSNs, are not
intact in ST14A cells. However, application of dopamine or Quin, increases CREB
Endogenous current from differentiated cells was significantly larger than endogenous current from round
cells (†; p < 0.05); Transfected current was significantly larger than endogenous current from round cells (‡;
p < 0.05); FPL significantly increased differentiated endogenous and transfected tail current (*; p < 0.05),
n = 7–15. (C) Transfected ST14A cells expressed GFP throughout the cell soma and in a small percentage of
differentiated cells, in the processes. Images (20X magnification) were captured ~24 hours post-transfection.
The transfection rate for these cells was ~50%. (D) Top: Protocol for eliciting currents from a holding potential
of -90 mV to the test potential of +10 mV for 100 ms before repolarizing to -40 ms. Individual traces from
round endogenous (middle) or round transfected (bottom) cells. Dashed lines indicate where peak and tail
current were measured 65 ms after depolarization and 15 ms after repolarization, respectively. In the
presence of LTC agonist, 1 μM FPL, both the peak and long-lasting tail current increase (gray trace) and
display slowed activation and deactivation kinetics, characteristic of FPL-induced L-current.
doi:10.1371/journal.pone.0132469.g001
L-Type Ca2+ Channel Modulation in ST14A Cells
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Fig 2. Whole-cell currents from transfected ST14A cells have biophysical and pharmacological
properties of CaV1.3 LTCs. (A) The current-voltage (I-V) relationship shows that recombinant CaV1.3
current activates at approximately -60 mV; n = 15. (B) Example time course of peak current at -10 mV. 1 μM
ω-conotoxin GVIA (CTX, an N-type Ca2+ channel antagonist) was added for 2 min. Bath solution was
exchanged with 1 μM nimodipine (NIM, an LTC antagonist) for 2 min or until a new stable baseline was
reached and then washed off to show reversibility. FPL (1 μM) was added at the end of the recording. (C)
Summary of pharmacological inhibition of transfected current; n = 3–6.
doi:10.1371/journal.pone.0132469.g002
L-Type Ca2+ Channel Modulation in ST14A Cells
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phosphorylation in ST14A cells, indicating that D2Rs do couple to intact signaling cascades
such as the adenylyl cyclase and MAPK pathways [29].
A non-selective D2R-like agonist, Quin also activates D3 and D4Rs [38]. Subsequently, D3
and D4Rs modulate immediate early gene expression [39, 40] raising the question of the iden-
tity of dopamine receptors in ST14A cells. Using RT-PCR, we examined dopamine receptor
(D1, D2, D3, D4, and D5) mRNA content in ST14A cells, striatum (positive control for all dopa-
mine receptors), cortex, A9L cells (D2R positive control; see Materials and Methods) or HEK
Fig 3. ST14A endogenous or recombinant CaV1.3 current is not modulated by GPCR activation. (A)
Time course (left) and representative sweeps (right) of recombinant CaV1.3 current before (FPL), 1 min
following 10 μM quinpirole application (Quin) and after removing Quin (Wash). (B–C) Endogenous,
differentiated current traces in the presence of FPL across a range of test potentials (-50 mV to 0 mV) before
(left) and after (right) application of (B) 10 μMQuin or (C) 10 μM oxotremorine M (Oxo-M). (D) Summary of
percent inhibition of peak (left) and long-lasting tail (right) recombinant CaV1.3 or endogenous currents by
D2R or M1R agonist; n = 3–7.
doi:10.1371/journal.pone.0132469.g003
L-Type Ca2+ Channel Modulation in ST14A Cells
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293 cells (negative control for all dopamine receptors). PCR products were detected for long
and short splice variants of the D2R in ST14A cells (n = 4/11 and 2/11, respectively, striatum
(n = 1/2 and 2/2, respectively), cortex (n = 1/2 for both) and A9L cells (n = 2/5 and 2/5, respec-
tively) as shown in Fig 4A. Additionally, D1R (n = 2/10), D4R (7/10), D5R (4/10) (data not
shown) mRNAs were also detected in ST14A cells, regardless of the temperature at which cells
were grown. D1R, D4R and D5R mRNAs were detected in striatum whereas D1R and D4R
mRNAs were detected in the cortex (data not shown). D4R mRNA was also detected in A9L
cells (n = 3/4). Experiments for D3R mRNA expression in striatum, cortex, and ST14A cell
samples resulted in a smear despite several attempts to adjust the protocol. HEK 293 cells
showed no expression of any of the dopamine receptors tested. These results show that ST14A
cells express mRNA for more than one D2-like receptor; this finding could account for the pre-
viously reported D2R-like changes in pCREB [29].
Since MSNs are GABAergic, a defining characteristeric of ST14A cells being MSN-like
would be expression of glutamic acid decarboxylase (GAD), the enzyme that catalyzes GABA
synthesis from glutamate. Using RT-PCR, we measured whether ST14A cells express GAD2
and GAD1, two genes which encode GAD with molecular weights of 65 and 67 kDa, respec-
tively. The primers used against GAD1 detect both embryonic and adult splice forms of
GAD67. All three bands corresponding to GAD65 and embryonic and adult GAD67 were
detected in ST14A cells (Fig 4B). Alternate lanes in which RNA samples were not reverse tran-
scribed served as controls for genomic DNA contamination and yielded no product. Using
striatal and cortical tissues as positive controls for the GAD genes, and in A9L cells, we detected
all three forms of GAD as well. In contrast, no bands for GAD65 and only faint bands for
GAD67 were detected in HEK 293 cells. The presence of GAD in ST14A cells further confirms
that this cell line exhibits GABAergic characteristics of MSNs.
After confirming ST14A cells exhibit a similar mRNA expression profile for dopamine
receptors and GAD as MSNs, we examined whether D2Rs and downstream signaling molecules
were expressed in ST14A cells. Using Western blot analysis, D2R and M1R expression was con-
firmed in ST14A cells. D2R antibodies recognized a band at 50 kDa, the expected molecular
weight of D2Rs (Fig 5A, top panel) for striatum and cortex (positive controls). A second band
at 75 kDa, absent in the A9L cell line, most likely represents a glycosylated form of the receptor
[41], further supporting the idea that the ST14A cells are similar to neurons in these brain
regions regarding post-translational modification of proteins. Fig 5A (middle panel) shows that
ST14A cells, but not A9L cells, express M1Rs, displayed as a 50 kDa band onWestern blots.
This antibody recognized M1R expression in SCG, striatum, and cortex [34]. Expression of
Gqα (Fig 5A, bottom panel), which couples to M1Rs, was also detected in the cell lines and tis-
sue samples at the predicted molecular weight of 42 kDa. These results show that ST14A cells
express D2R, M1R and Gqα proteins.
Since D2Rs and M1Rs both couple to PLCβ-1, we examined whether ST14A cells express
PLCβ-1. Protein expression of PLCβ-1 was not detected in either the A9L or ST14A cell lines,
but was detected in SCG tissue (Fig 5B). The unanticipated absence of PLCβ-1 may account for
the lack of CaV1.3 modulation since PLCβ-1 is required for LTC current inhibition by both the
D2R and M1R pathways [10, 42]. To determine the presence of molecules downstream of
PLCβ-1 reported to participate in LTC modulation by these receptors [10, 25], we tested for
cPLA2 and PP2B expression. Fig 5C shows that ST14A cells cultured at 33 and 37°C, as well as
A9L cells, express cPLA2. cPLA2 was detected at low expression levels from postnatal day 1
SCG (positive control) as has been reported previously [25]. Fig 5D shows that ST14A cells
also express PP2B. Since PLCβ-1 is downstream of both D2 and M1Rs, this result may explain
our lack of inhibition of CaV1.3 or endogenous LTC current by Quin or Oxo-M in ST14A cells.
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Fig 4. ST14A cells express several D2R family mRNAs. ST14AmRNA transcripts were amplified by
RT-PCR. (A) D2R mRNA expression in ST14A, A9L, HEK 293 cells and in striatum. A9L cells that express
D2Rs and striatum served as positive controls. Left lane contains a 100 bp ladder; brightest band is 600 bp.
The band for ST14A cells was sequenced and BLAST search results matched previously published
sequences for D2Rs. No D2R bands were detected in HEK 293 cells. (B) GAD65/67 mRNA expression in
ST14A, striatum, cortex, A9L and HEK 293 cells. As a control, ST14AmRNAwas not reverse-transcribed (-
RT).
doi:10.1371/journal.pone.0132469.g004
L-Type Ca2+ Channel Modulation in ST14A Cells
PLOS ONE | DOI:10.1371/journal.pone.0132469 July 6, 2015 11 / 19
To circumvent the absence of a key signaling molecule, and determine whether CaV1.3
could be modulated, we directly applied exogenous AA (10 μM) to the bath and measured
CaV1.3 recombinant current over several minutes. In the presence of FPL, AA inhibited CaV1.3
peak and long-lasting tail currents by 40 ± 12% and 29 ± 25% respectively after 1 min (n = 4).
Fig 6A shows representative sweeps before (FPL) and after AA application (FPL + AA). The
large variability in tail current inhibition by AA suggested that voltage may be important for
this modulation. However, AA inhibited CaV1.3 current at all voltages when tested over a
range of test potentials as shown in the I-V plot in Fig 6B. Bovine serum albumin (BSA), which
binds free fatty acids [43], reversed inhibition at all test potentials. To show that inhibition was
Fig 5. Expression of D2R and M1R signaling pathway proteins in ST14A cells. (A) Top: D2R expression
in ST14A cells, A9L cells (positive control) and tissues: SCG (superior cervical ganglia), STR (striatum,
positive control), CTX (cortex). The predicted molecular weight (MW) for the D2R is 50 kDa. The 75 kDa form
may represent a glycosylated form of the D2R versus long and short D2R splice variants, which differ by ~40
amino acids and would not account for this MW difference.Middle: M1R expression in ST14A or A9L cells.
The predicted MW of M1Rs is 50 kDa. Bottom: Gqα expression in both cell lines and brain tissues. The
predicted MW for Gqα is 42 kDa. (B) PLCβ-1 expression, or absence, in SCG, A9L or ST14A cells at various
temperatures. The antibody recognizes PLCβ-1 fragments at 100 and 41 kDa. (M, lane for MW ladder) (C)
The presence of cPLA2 in SCG neurons at postnatal day 1 (P1) or 4 (P4) or adult (A), A9L and ST14A cells
under varying conditions. The predicted MW for cPLA2 is 110 kDa. β-actin, MW of 42 kDa, is shown as a
loading control. (D) PP2B in ST14A cells loaded at varying concentrations; predicted MW of the α-subunit is
61 kDa.
doi:10.1371/journal.pone.0132469.g005
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not due to AA competing with FPL, we measured CaV1.3 current in the absence of FPL prior
to and after application of AA (Fig 6C) and still observed inhibition that could be reversed
after adding BSA. Inhibition of CaV1.3 over time by AA (open bars) and recovery by BSA
(solid bar) is summarized in Fig 6D. Conversely, oleic acid (10 μM) enhanced current by
7.9 ± 0.7% after 1 minute (Fig 6E; p< 0.001; n = 3), suggesting that inhibition by AA is not
simply the result of a nonspecific fatty acid effect. Moreover, inhibition of CaV1.3 by AA dem-
onstrates that the transfected CaV1.3 LTCs in ST14A cells are capable of modulation.
Discussion
MSNs have a resting membrane potential that oscillates between ~ -85 mV (during the “down”
state) and ~-60 mV (during the “up” state) [4, 6]. Inhibition of CaV1.3 is of particular interest
in MSNs because it activates at potentials approximately 25 mVmore negative than CaV1.2,
[30]. Since CaV1.3 activates at the low voltage of -60 mV, this channel may open during the
“up” state and contribute to reaching threshold for firing an action potential [4]. Moreover,
Fig 6. Transfected CaV1.3 currents in ST14A cells are inhibited by AA. (A) Individual sweeps with 1 μM
FPL (black trace), and 1 min after 10 μMAA (dotted trace) in the continued presence of FPL. AA inhibited
both peak and tail currents; n = 4. (B) I-V relationship of recombinant current in the presence of FPL (●), FPL
+ AA (), and after washing off AA with bath solution containing FPL (Δ). (C) Time course of CaV1.3 current at
-10 mV with 10 μMAA. After 4 min, AA was washed off with 1 mg/ml BSA. (D) Summary of CaV1.3 current
inhibition by AA over time (open bars) and its recovery following BSA (Black bar); *p < 0.001; n = 5–7. (E)
Time course of peak CaV1.3 current with 10 μM oleic acid (OA); n = 3.
doi:10.1371/journal.pone.0132469.g006
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increased D2R signaling or inhibition of LTCs in MSNs decreases membrane excitability [10].
MSN activity produces the only output from the striatum and thus the finely tuned regulation
of MSN activity is critical for normal motor function. Disruption of MSN regulation results in
severe malfunction of the basal ganglia, as seen when MSNs lose dopaminergic input in Parkin-
son’s disease, or when MSNs undergo cell death as seen in Huntington’s disease [5, 44].
Because studying Ca2+ currents in MSNs has been challenging, we searched for a cell line that
might serve as a model system for MSNs. However, remarkably few neuronal cell lines have been
developed despite ongoing demand for their use in biophysical studies of ion channels and in
high through put systems for therapeutic drug testing. We hypothesized that ST14A cells, com-
pared to HEK 293 cells, would express postsynaptic endogenous D2R signaling microdomains
closely matching MSNs, thus making ST14A cells useful for studying CaV1.3 modulation by D2R
specific signaling. Therefore we examined ST14A cells to determine whether this cell line exhibits
sufficient striatal properties to serve as a suitable model system for studying MSN functioning.
We first tested whether ST14A cells express endogenous voltage-gated Ca2+ current.
We characterized a small, endogenous Ca2+ current from differentiated ST14A cells that
develop neuronal-like processes when grown at 37°C. However, we found that only 5/15 cells
had a current amplitude larger than 200 pA even in the presence of the LTC agonist FPL. This
small current and the relatively low number of cells expressing a measurable current, is similar
to previous findings [29]. K+, Na+ and HCN-mediated currents, in addition to the ability to fire
action potentials, are also reported in a small percentage of ST14A cells [29, 45, 46]. However,
when present, the Ca2+ current was within the lower range of current amplitudes recorded in
MSNs, and was similar to L-current in MSNs in that the tail current was sensitive to LTC ago-
nists, increasing ~ 6-fold following exposure to FPL. L-current dominates few types of neurons;
one of them being MSNs (e.g., [10] [47]). Though the Ca2+ current in differentiated ST14A
cells is small, L-current appears to make up much of the whole-cell Ca2+ current. Further opti-
mization of culture conditions and/or recording conditions may increase CaV1.3 expression
and consequently L-current amplitudes.
As an alternative strategy to examining native CaV1.3 activity in ST14A cells, we attempted
to transiently transfect round ST14A cells, which lack endogenous Ca2+ currents, with LTC
channel subunits and GFP. We didn’t know whether ST14A cells would tolerate transfection of
the multiple Ca2+ channel subunits as well as express functional channels. However ST14A
cells were transfected successfully with channel subunits and exhibited robust voltage-gated
Ca2+ currents. We characterized the biophysical properties of isolated, recombinant CaV1.3
current in a striatal-like background without the complications of primary MSNs, i.e., requir-
ing several pharmacological blockers to silence other ionic or multiple types of Ca2+ currents.
These large currents appeared ideal for testing whether ST14A cells would support CaV1.3 cur-
rent inhibition by the D2R agonist.
From the biochemical characterization of ST14A cells as MSN-like due to the expression of
dopamine receptors (D1, D2, D4, D5) and GAD65/67 mRNAs as well as expression of D2R,
M1R, Gqα, cPLA2 and PP2B protein we anticipated observing LTC modulation. However, no
inhibition of CaV1.3 current was observed with Quin or Oxo-M. Since PLCβ-1 expression is so
widespread, we tested for its expression in ST14A cells only after finding no LTC modulation
by Quin. Lack of PLCβ-1 protein expression was unexpected since several intact signaling cas-
cades are described in the growing literature regarding ST14A cells. Most notably, ST14A cells
have functional CREB phosphorylation following D2R stimulation and Ras/MAPK, adenylyl
cyclase, Wnt and JAK/STAT signaling pathways [29, 48–51]. Moreover these cells express
other enzymes that act on lipids including N-acyl-phosphatidylethanolamine-hydrolyzing
phospholipase D (NAPE-PLD), fatty acid amide hydrolase, diacylglyceride lipase, monoacyl-
glycerol lipase (Bari et al., 2013), and cPLA2 (Fig 3C).
L-Type Ca2+ Channel Modulation in ST14A Cells
PLOS ONE | DOI:10.1371/journal.pone.0132469 July 6, 2015 14 / 19
The absence of PLCβ-1 expression in ST14A cells coincides with the lack of CaV1.3 current
inhibition by either Quin or Oxo-M, supporting the importance of PLCβ-1 for both D2R and
M1R signal transduction pathways [10, 52, 53]. Despite PLCβ-1’s absence, it was not obvious
that no other variant of PLCβ would substitute for the missing PLCβ-1. The absence of PLCβ-1
and its apparent requirement for D2R signaling will be of interest to researchers who study
MSNs. Interestingly, PLCβ-1 has been implicated in regulating growth and proliferation,
where its absence results in uncontrolled cell proliferation [54, 55]. Thus a loss of PLCβ-1 may
have occurred during the immortalization of ST14A cells.
In these experiments, we used a short splice variant of CaV1.3, CaV1.3b [30]. CaV1.3a,
which has a longer C-terminus, was not inhibited by activation of D2Rs when expressed in
HEK 293 cells [56]; however, CaV1.3a has been shown to bind the scaffolding protein Shank
found in the postsynaptic density of synapses [57]. This association is necessary for CaV1.3 cur-
rent inhibition by D2Rs in primary MSNs [11]. Although the lack of the long C-terminus also
could explain the absence of channel modulation by D2Rs in ST14A cells, CaV1.3b LTCs can
be modulated by both IGF-1 and AA. Exposure of SH-SY5Y cells expressing either CaV1.3a or
CaV1.3b to IGF-1 enhances both currents and requires phosphorylation of S1486, a residue
shared by both splice variants [58]. We have measured significant CaV1.3b inhibition by AA in
transiently transfected HEK 293 cells, consistent with a potential transmembrane site of action
[27].
Since AA release occurs in the striatum from both neurons and astrocytes [59–61] following
stimulation of D2Rs [21] or M1Rs [62], we tested whether bath application of AA modulated
LTC in ST14A cells to be certain that CaV1.3b could be modulated by molecules downstream
of PLCβ-1. We were unsure whether AA would inhibit CaV1.3b channels in ST14A cells simi-
larly to CaV1.3 channels in HEK 293 cells [27] or native LTCs in SCG neurons [23–25] since a
wide range of actions have been reported for AA modulation of a variety of Ca2+ currents by
other groups (see review by Roberts-Crowley et al [63]). We found that direct application of
AA circumvented the lack of receptor-activated channel modulation in ST14A cells and inhib-
ited CaV1.3b recombinant current. This finding demonstrates that CaV1.3 channels are capable
of being modulated in ST14A cells as we have observed previously in HEK 293 cells [27]. The
properties of CaV1.3 inhibition by AA in HEK 293 and ST14A cells appear similar. Addition-
ally we have found that Oxo-M inhibits currents from CaV1.3b in HEK 293 cells stably trans-
fected with M1Rs (unpublished data). Lastly, we have found that activation of D2Rs by 10 μM
Quin inhibits CaV2.2 currents in HEK 293 cells (unpublished data) demonstrating that this
agonist protocol should be sufficient to activate D2Rs in ST14A cells. Therefore, the lack of cur-
rent modulation by D2Rs or M1Rs, reported here, is supported by the absence of PLCβ-1 rather
than an inability of CaV1.3b to respond to modulation.
Conclusions
ST14A cells are used as a model system for both the study and treatment of Huntington’s dis-
ease [64–69]. Despite the lack of D2R- or M1R-mediated Ca
2+ channel modulation in ST14A
cells reported here, this cell line was useful for elucidating that AA inhibits CaV1.3 channels.
We hypothesize that the consistency of AA’s inhibitory actions on CaV1.3 across cell types will
be of interest to researchers who study lipid signaling molecules. Moreover, we anticipate the
D2R signaling cascade could be rescued by transfecting ST14A cells with PLCβ-1. Whether
D2R signaling would then cause a lipid mediated inhibition of CaV1.3b LTCs awaits future
studies. Thus, ST14A cells are a valuable tool for studying the biophysical properties of an iso-
lated Ca2+ current and the modulation of these channels by signaling molecules within the con-
text of a striatal background to aid in understanding neuronal malfunctions of the striatum.
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